A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.
about
Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsyTopiramate add-on for drug-resistant partial epilepsyTopiramate add-on for drug-resistant partial epilepsyAntiepileptic Drug Treatment in Children with EpilepsyPharmacology aspects during transition and at transfer in patients with epilepsyTopiramate monotherapy in infantile spasmRole of oxidative stress in epileptic seizures.Randomized trial of adjunctive topiramate therapy in infants with refractory partial seizures.Topiramate add-on for drug-resistant partial epilepsy.Efficacy and tolerability of the new antiepileptic drugs, II: Treatment of refractory epilepsy: report of the TTA and QSS Subcommittees of the American Academy of Neurology and the American Epilepsy Society.Topiramate.Nephrolithiasis in topiramate users.Pharmacokinetics and pharmacodynamics of topiramate.Beneficial and adverse psychotropic effects of antiepileptic drugs in patients with epilepsy: a summary of prevalence, underlying mechanisms and data limitations.New generation anticonvulsants for the treatment of epilepsy in children.A revisited strategy for antiepileptic drug development in children: designing an initial exploratory step.Advances in our understanding of early childhood epilepsies: 1999-2000.Pediatric partial and generalized seizures.Drug treatment of epilepsy in the century of the ILAE: the second 50 years, 1959-2009.Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis.Clinical experience with open-label topiramate use in infants younger than 2 years of age.Antiepileptic drug development for "therapeutic orphans".Effects of topiramate on cognitive function.Short term outcomes of topiramate monotherapy as a first-line treatment in newly diagnosed West syndrome.International Veterinary Epilepsy Task Force consensus proposal: medical treatment of canine epilepsy in EuropeBehavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients.Pharmacotherapy for Dravet Syndrome.Evaluate the Efficacy and Safety of Anti-Epileptic Medications for Partial Seizures of Epilepsy: A Network Meta-Analysis.Topiramate and its clinical applications in epilepsy.Epilepsy-related injuries.The adverse effects of antiepileptic drugs in children.Increased propensity for calcium phosphate kidney stones with topiramate use.Topiramate: a review of its use in the treatment of epilepsy.Antiepileptic drug development in children: considerations for a revisited strategy.Spotlight on topiramate in epilepsy.Topiramate in the treatment of partial and generalized epilepsy.Use of second-generation antiepileptic drugs in the pediatric population.Placebo-corrected efficacy of modern antiepileptic drugs for refractory epilepsy: systematic review and meta-analysis.Does one more medication help? Effect of adding another anticonvulsant in childhood epilepsy.Pharmacotherapy for children and adolescents with epilepsy.
P2860
Q21563404-162422E2-49A9-4F29-AC51-1D5E6615FDC1Q24200264-7E9EB539-39E4-463C-93D2-D414C5E3BD12Q24242030-AA067442-D7B9-4501-ABFA-D47659CFEB2BQ26781771-66C04715-28EE-41CF-BEC4-89E457CE2FBAQ27026408-029FF593-75F9-4F33-8F82-75EECCA4E116Q28468637-55EA98BF-7185-4184-A745-0711DE1FBBBCQ30456096-7A6D1725-1B94-4057-A95B-B1E989FDA4F1Q30493600-AA89DE71-9BE2-495D-BB82-F739DB63736DQ30838737-3B02C01F-AE2E-4205-83CC-6ED8B513EE99Q33202111-DB06C722-0CC8-4E76-B002-C3C58B45875BQ33756793-109627E0-D3B0-4D22-B9BA-8E915880DB6EQ33919910-7AC260C8-8E44-4E59-B8ED-0B49E1E49B12Q34161725-69904E76-1813-4BBD-97FC-5D2FBAB8CD67Q34186198-C1FA28E8-55B7-4F9F-86AF-01551F042151Q34504288-94031080-A3B2-43E1-802C-FC8B4DC3697EQ34560399-E17B8718-ADA3-437B-95EA-AE8F9AE910ECQ34566532-8E52C871-4823-458E-811D-27D4E7812B70Q34579465-46068490-EF32-409C-9EE4-56F2C2F0A409Q34965263-0144B1C4-845E-4C09-81D1-E91836654380Q34976048-5BA5DB28-5700-4D96-B29D-AD41A97A2F15Q35132987-678CF78A-4956-48CA-8C3E-9338FE895180Q35200123-794383A4-8DC7-4FB8-925C-27B7B6006AB2Q35572162-517B304E-D953-4400-8773-9B070DA05553Q35649274-58FC0B28-344B-4617-BFF0-28B81B684AE0Q35758344-7CE5A741-A57F-4F72-8213-AB89FD12C5CEQ35939591-83F6D39F-C064-487A-A492-97C7FA797005Q35953476-8387AECC-B89D-48CF-B3EB-4D145C18D172Q36284727-48239ED1-82BF-4E10-84EA-8A18EDA3CD07Q36429751-C1BF0E24-4991-4CC0-9B31-59242B6A3DD9Q36625022-AF15C709-CC15-4DC0-A7E6-B8A1F394E09FQ36811532-5B5290E7-D39E-45E3-A09D-37AC77A74FC4Q36945018-E34D1520-60E1-4C4F-BBBA-0128408C561AQ36967168-2D0A68EA-164A-45AD-ABF6-161B3C5420D1Q37032549-343B7D42-A2F3-4453-87A8-337569224858Q37056600-71FC8A52-0F57-4093-9A85-12E035743145Q37129817-70CC217F-AD6B-44C7-95C5-8373C740C9F0Q37203259-C1CE4991-587C-4A06-8E7B-917BDB5D3DF7Q37594857-D6F713F4-4A6A-4676-B18A-43962926C67DQ37823805-4228EBAE-FA89-4C3F-9D9A-C3C484574134Q37826193-3BBBB155-12DB-4154-AB67-D5DAF97830E2
P2860
A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh-hant
name
A double-blind, randomized tri ...... en. Topiramate YP Study Group.
@en
A double-blind, randomized tri ...... en. Topiramate YP Study Group.
@nl
type
label
A double-blind, randomized tri ...... en. Topiramate YP Study Group.
@en
A double-blind, randomized tri ...... en. Topiramate YP Study Group.
@nl
prefLabel
A double-blind, randomized tri ...... en. Topiramate YP Study Group.
@en
A double-blind, randomized tri ...... en. Topiramate YP Study Group.
@nl
P2093
P356
P1433
P1476
A double-blind, randomized tri ...... en. Topiramate YP Study Group.
@en
P2093
P304
P356
10.1212/WNL.52.7.1338
P407
P577
1999-04-01T00:00:00Z